2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD - Research - The Capital Region of Denmark

Research

Print page

Print page

Switch language

The Capital Region of Denmark - a part of Copenhagen University Hospital

Published

2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD

Research output: Contribution to journal › Journal article › Research › peer-review

DOI

https://doi.org/10.1016/j.recesp.2019.11.024
Final published version

From the same journal

Triple Antithrombotic Therapy: Risky but Sometimes Necessary
Research output: Contribution to journal › Journal article › Research › peer-review
Telecardiology: past, present and future
Research output: Contribution to journal › Journal article › Research › peer-review
Grupo de Trabajo para el manejo del infarto agudo de miocardio con elevación del segmento ST de la Sociedad Europea de Cardiología (ESC)
Research output: Contribution to journal › Journal article › Research › peer-review

By the same author

Acute and Long-Term Treatment With Dapagliflozin and Association With Serum Soluble Urokinase Plasminogen Activator Receptor
Research output: Contribution to journal › Journal article › Research › peer-review
Cardiovascular Autonomic Neuropathy in Type 1 Diabetes Is Associated With Disturbances in TCA, Lipid, and Glucose Metabolism
Research output: Contribution to journal › Journal article › Research › peer-review
Randomized Controlled Trial of the Hemodynamic Effects of Empagliflozin in Patients With Type 2 Diabetes at High Cardiovascular Risk: The SIMPLE Trial
Research output: Contribution to journal › Journal article › Research › peer-review
Effect of empagliflozin on myocardial structure and function in patients with type 2 diabetes at high cardiovascular risk: the SIMPLE randomized clinical trial
Research output: Contribution to journal › Journal article › Research › peer-review
Effect of the Glucagon-like Peptide-1 Receptor Agonists Semaglutide and Liraglutide on Kidney Outcomes in Patients With Type 2 Diabetes: Pooled Analysis of SUSTAIN 6 and LEADER
Research output: Contribution to journal › Journal article › Research › peer-review

View graph of relations

Original language	English
Journal	Revista Espanola de Cardiologia (Online)
Volume	73
Issue number	5
Pages (from-to)	404.e1-404.e59
ISSN	0300-8932
DOIs	https://doi.org/10.1016/j.recesp.2019.11.024
Publication status	Published - 1 May 2020

ID: 59809512